Farmacias Benavides S.A.B. de C.V. (BEVIDESB)
Mexican Exchange · Mexico · prices in MXN · close of 15 Oct 2026
Key indicators
| Last close | MXN 25.00 |
|---|---|
| 52-week range | 25.00 – 26.00 |
| Return, 1 month / 3 months | +0.0% / +0.0% |
| Return, 1 year / 3 years | +0.0% / +31.6% |
| Trend | Below its 200-day average |
| RSI (14) | 14 |
| Volatility (1 year) | 6.3% |
| Worst drawdown (1 year) | -3.8% |
| Average daily value traded | 0.00M MXN |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Farmacias Benavides is a Mexican pharmacy chain based in Monterrey that runs drugstores serving local communities across the country. Its stores offer prescription and over-the-counter medicines, health and personal care products, and everyday household goods, along with services such as filling prescriptions. The company serves individual shoppers and families who visit its neighbourhood outlets for their health and daily needs.
On this site Farmacias Benavides S.A.B. de C.V. appears as a stock on the Mexican Exchange (Mexico), code BEVIDESB, with prices in Mexican pesos (MXN). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Farmacias Benavides S.A.B. de C.V. (BEVIDESB) trades on the Mexican Exchange in Mexico. It last closed at MXN 25.00 on 15 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 198 of 361 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.0% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Mexican Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 42 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -2.3% | ||
| From 52-week high | -3.8% | ||
| Momentum | 36 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 0.0% | ||
| 6-month return | -3.8% | ||
| 12-month return, skipping the last month | 0.0% | ||
| Stability (higher is calmer) | 96 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 6.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -3.8% | ||
| Liquidity | 3 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M MXN | ||
| Zero-volume days | 100.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | +0.0% |
| 6 months | −3.8% |
| 1 year | +0.0% |
| 3 years | +31.6% |
| 5 years | +107.6% |
Signals
| 50-day / 200-day average | 25.00 / 25.58 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.00 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Mexican Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.